Cart

Remove item Thumbnail image Product Price Quantity Subtotal
TYLOXAPOL Drug Excipient Business Development Opportunity Report, 2024 TYLOXAPOL Drug Excipient Business Development Opportunity Report, 2024 $399.00
$399.00
SUCROSE DISTEARATE Drug Excipient Business Development Opportunity Report, 2024 SUCROSE DISTEARATE Drug Excipient Business Development Opportunity Report, 2024 $399.00
$399.00
STARCH, CORN Drug Excipient Business Development Opportunity Report, 2024 STARCH, CORN Drug Excipient Business Development Opportunity Report, 2024 $399.00
$399.00

Cart totals

Subtotal $1,197.00
Total $1,197.00
ChemIntel360
Scroll to Top